BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19284570)

  • 1. Cost effectiveness of antimicrobial catheters in the intensive care unit: addressing uncertainty in the decision.
    Halton KA; Cook DA; Whitby M; Paterson DL; Graves N
    Crit Care; 2009; 13(2):R35. PubMed ID: 19284570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation.
    Hockenhull JC; Dwan K; Boland A; Smith G; Bagust A; Dündar Y; Gamble C; McLeod C; Walley T; Dickson R
    Health Technol Assess; 2008 Apr; 12(12):iii-iv, xi-xii, 1-154. PubMed ID: 18405471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT.
    Gilbert R; Brown M; Faria R; Fraser C; Donohue C; Rainford N; Grosso A; Sinha AK; Dorling J; Gray J; Muller-Pebody B; Harron K; Moitt T; McGuire W; Bojke L; Gamble C; Oddie SJ
    Health Technol Assess; 2020 Nov; 24(57):1-190. PubMed ID: 33174528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New choices for central venous catheters: potential financial implications.
    Shorr AF; Humphreys CW; Helman DL
    Chest; 2003 Jul; 124(1):275-84. PubMed ID: 12853534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection.
    Veenstra DL; Saint S; Sullivan SD
    JAMA; 1999 Aug; 282(6):554-60. PubMed ID: 10450717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
    Lai NM; Chaiyakunapruk N; Lai NA; O'Riordan E; Pau WS; Saint S
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD007878. PubMed ID: 26982376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which antimicrobial impregnated central venous catheter should we use? Modeling the costs and outcomes of antimicrobial catheter use.
    Marciante KD; Veenstra DL; Lipsky BA; Saint S
    Am J Infect Control; 2003 Feb; 31(1):1-8. PubMed ID: 12548250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CATheter Infections in CHildren (CATCH): a randomised controlled trial and economic evaluation comparing impregnated and standard central venous catheters in children.
    Harron K; Mok Q; Dwan K; Ridyard CH; Moitt T; Millar M; Ramnarayan P; Tibby SM; Muller-Pebody B; Hughes DA; Gamble C; Gilbert RE
    Health Technol Assess; 2016 Mar; 20(18):vii-xxviii, 1-219. PubMed ID: 26935961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial.
    Bonne S; Mazuski JE; Sona C; Schallom M; Boyle W; Buchman TG; Bochicchio GV; Coopersmith CM; Schuerer DJ
    J Am Coll Surg; 2015 Sep; 221(3):739-47. PubMed ID: 26199017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of a central venous catheter care bundle.
    Halton KA; Cook D; Paterson DL; Safdar N; Graves N
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units.
    Ramritu P; Halton K; Collignon P; Cook D; Fraenkel D; Battistutta D; Whitby M; Graves N
    Am J Infect Control; 2008 Mar; 36(2):104-17. PubMed ID: 18313512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful?
    Saint S; Veenstra DL; Lipsky BA
    Infect Control Hosp Epidemiol; 2000 Jun; 21(6):375-80. PubMed ID: 10879567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial.
    Schuerer DJ; Zack JE; Thomas J; Borecki IB; Sona CS; Schallom ME; Venker M; Nemeth JL; Ward MR; Verjan L; Warren DK; Fraser VJ; Mazuski JE; Boyle WA; Buchman TG; Coopersmith CM
    Surg Infect (Larchmt); 2007 Aug; 8(4):445-54. PubMed ID: 17883361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of catheter-related blood stream infection: back to basics?
    Cherry-Bukowiec JR; Denchev K; Dickinson S; Chenoweth CE; Zalewski C; Meldrum C; Sihler KC; Brunsvold ME; Papadimos TJ; Park PK; Napolitano LM
    Surg Infect (Larchmt); 2011 Feb; 12(1):27-32. PubMed ID: 21171811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antiseptic-impregnated urethral catheters (the CATHETER trial).
    Pickard R; Lam T; Maclennan G; Starr K; Kilonzo M; McPherson G; Gillies K; McDonald A; Walton K; Buckley B; Glazener C; Boachie C; Burr J; Norrie J; Vale L; Grant A; N'dow J
    Health Technol Assess; 2012 Nov; 16(47):1-197. PubMed ID: 23199586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dressings and securement devices for central venous catheters (CVC).
    Ullman AJ; Cooke ML; Mitchell M; Lin F; New K; Long DA; Mihala G; Rickard CM
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD010367. PubMed ID: 26358142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
    Fraenkel D; Rickard C; Thomas P; Faoagali J; George N; Ware R
    Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis.
    Walder B; Pittet D; Tramèr MR
    Infect Control Hosp Epidemiol; 2002 Dec; 23(12):748-56. PubMed ID: 12517018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.
    Maki DG; Stolz SM; Wheeler S; Mermel LA
    Ann Intern Med; 1997 Aug; 127(4):257-66. PubMed ID: 9265424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nurse staffing and antimicrobial-impregnated central venous catheters on the risk for bloodstream infections in intensive care units.
    Alonso-Echanove J; Edwards JR; Richards MJ; Brennan P; Venezia RA; Keen J; Ashline V; Kirkland K; Chou E; Hupert M; Veeder AV; Speas J; Kaye J; Sharma K; Martin A; Moroz VD; Gaynes RP
    Infect Control Hosp Epidemiol; 2003 Dec; 24(12):916-25. PubMed ID: 14700407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.